Timothy England
Timothy England
Verifierad e-postadress på nottingham.ac.uk
Titel
Citeras av
Citeras av
År
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial
N Sprigg, K Flaherty, JP Appleton, RAS Salman, D Bereczki, M Beridze, ...
The Lancet 391 (10135), 2107-2115, 2018
1862018
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ...
The Lancet 393 (10168), 265-274, 2019
1472019
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2 …
D Wilson, G Ambler, C Shakeshaft, MM Brown, A Charidimou, ...
The Lancet Neurology 17 (6), 539-547, 2018
1362018
Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in …
C Geeganage, M Tracy, T England, G Sare, T Moulin, F Woimant, ...
Stroke 42 (2), 491-493, 2011
1172011
Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke
PMW Bath, N Sprigg, T England
Cochrane Database of Systematic Reviews, 2013
1132013
Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled …
TJ England, M Abaei, DP Auer, J Lowe, DRE Jones, G Sare, M Walker, ...
Stroke 43 (2), 405-411, 2012
1042012
Outcome of intracerebral hemorrhage associated with different oral anticoagulants
D Wilson, DJ Seiffge, C Traenka, G Basir, JC Purrucker, T Rizos, ...
Neurology 88 (18), 1693-1700, 2017
1012017
Cannabidiol protects an in vitro model of the blood–brain barrier from oxygen‐glucose deprivation via PPARγ and 5‐HT1A receptors
WH Hind, TJ England, SE O'Sullivan
British journal of pharmacology 173 (5), 815-825, 2016
952016
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint …
CS Anderson, Y Huang, RI Lindley, X Chen, H Arima, G Chen, Q Li, ...
The Lancet 393 (10174), 877-888, 2019
932019
RECAST (remote ischemic conditioning after stroke trial) a pilot randomized placebo controlled phase II trial in acute ischemic stroke
TJ England, A Hedstrom, S O’Sullivan, R Donnelly, DA Barrett, S Sarmad, ...
Stroke 48 (5), 1412-1415, 2017
882017
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type
D Wilson, A Charidimou, C Shakeshaft, G Ambler, M White, H Cohen, ...
Neurology 86 (4), 360-366, 2016
852016
Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: a systematic review
TJ England, CL Gibson, PMW Bath
Brain research reviews 62 (1), 71-82, 2009
792009
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a …
PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ...
The Lancet 391 (10123), 850-859, 2018
782018
Cannabinoids in experimental stroke: a systematic review and meta-analysis
TJ England, WH Hind, NA Rasid, SE O'sullivan
Journal of Cerebral Blood Flow & Metabolism 35 (3), 348-358, 2015
772015
Endocannabinoids modulate human blood–brain barrier permeability in vitro
WH Hind, C Tufarelli, M Neophytou, SI Anderson, TJ England, ...
British journal of pharmacology 172 (12), 3015-3027, 2015
732015
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ...
The Lancet 393 (10191), 2613-2623, 2019
702019
Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial
PM Bath, P Scutt, CS Anderson, JP Appleton, E Berge, L Cala, M Dixon, ...
The Lancet 393 (10175), 1009-1020, 2019
682019
A systematic review of cannabidiol dosing in clinical populations
SA Millar, NL Stone, ZD Bellman, AS Yates, TJ England, SE O'Sullivan
British journal of clinical pharmacology 85 (9), 1888-1900, 2019
632019
Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke …
TJ England, PMW Bath, GM Sare, C Geeganage, T Moulin, D O'Neill, ...
Stroke 41 (12), 2834-2839, 2010
592010
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
D Wilson, G Ambler, KJ Lee, JS Lim, M Shiozawa, M Koga, L Li, ...
The Lancet Neurology 18 (7), 653-665, 2019
542019
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20